Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avinger Inc (AVGR)

Avinger Inc (AVGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,395
  • Shares Outstanding, K 16,793
  • Annual Sales, $ 7,920 K
  • Annual Income, $ -27,560 K
  • 60-Month Beta 1.74
  • Price/Sales 0.38
  • Price/Cash Flow N/A
  • Price/Book 0.72
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.07
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/04/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -3.10
  • Growth Rate Est. (year over year) +32,325.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.59 +4.92%
on 01/31/20
1.26 -50.87%
on 01/21/20
-0.46 (-42.69%)
since 01/14/20
3-Month
0.59 +4.92%
on 01/31/20
1.63 -62.02%
on 11/21/19
-0.27 (-30.44%)
since 11/14/19
52-Week
0.59 +4.92%
on 01/31/20
12.60 -95.09%
on 04/10/19
-3.68 (-85.60%)
since 02/14/19

Most Recent Stories

More News
Avinger's Pantheris Featured in Live Case Transmission at LINC 2020

REDWOOD, CA / ACCESSWIRE / February 4, 2020 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.62 (+1.48%)
Avinger Closes $4.5 Million Equity Offering

REDWOOD CITY, CA / ACCESSWIRE / January 31, 2020 / Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten...

AVGR : 0.62 (+1.48%)
Avinger Announces the Passing of Director Donald A. Lucas

REDWOOD CITY, CA / ACCESSWIRE / January 30, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 0.62 (+1.48%)
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

REDWOOD CITY, CA / ACCESSWIRE / January 28, 2020 / Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten...

AVGR : 0.62 (+1.48%)
Avinger Enrolls First Patient in IMAGE-BTK Clinical Study Evaluating Safety and Efficacy Endpoints for Pantheris SV

Post-Market Study Intended to Support Commercial Expansion of Small Vessel Image-Guided Atherectomy Device

AVGR : 0.62 (+1.48%)
Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion (CTO) Image-Guided Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / January 9, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.62 (+1.48%)
Avinger Receives CE Marking for Ocelaris, a Next-Generation Image-Guided CTO Crossing System

REDWOOD CITY, CA / ACCESSWIRE / December 17, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems...

AVGR : 0.62 (+1.48%)
Avinger Appoints Healthcare Veteran Tamara Elias, MD, to Board of Directors

REDWOOD, CA / ACCESSWIRE / December 16, 2019 / Avinger, Inc. (NASDAQ:), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis...

AVGR : 0.62 (+1.48%)
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

QLYS : 92.44 (+2.62%)
CYBR : 118.94 (+0.63%)
AVGR : 0.62 (+1.48%)
ONVO : 0.33 (unch)
ALXN : 102.56 (-0.83%)
What Bargain Hunting? Tap 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E for outsized gains.

QLYS : 92.44 (+2.62%)
CYBR : 118.94 (+0.63%)
AVGR : 0.62 (+1.48%)
ALXN : 102.56 (-0.83%)
ONVO : 0.33 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade AVGR with:

Business Summary

Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City,...

See More

Key Turning Points

2nd Resistance Point 0.64
1st Resistance Point 0.63
Last Price 0.62
1st Support Level 0.61
2nd Support Level 0.60

See More

52-Week High 12.60
Fibonacci 61.8% 8.01
Fibonacci 50% 6.60
Fibonacci 38.2% 5.18
Last Price 0.62
52-Week Low 0.59

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar